575 Dual blockade of LAG3 and TIGIT improves the treatment efficacy of a nanoparticle-mediated immunoradiation in anti-PD1 resistant lung cancer in mice

Similar Items

• Combining a nanoparticle-mediated immunoradiotherapy with dual blockade of LAG3 and TIGIT improves the treatment efficacy in anti-PD1 resistant lung cancer
  by: Yun Hu, et al.
  Published: (2022-09-01)
• A radioenhancing nanoparticle mediated immunoradiation improves survival and generates long-term antitumor immune memory in an anti-PD1-resistant murine lung cancer model
  by: Yun Hu, et al.
  Published: (2021-12-01)
• High Plus Low Dose Radiation Strategy in Combination with TIGIT and PD1 Blockade to Promote Systemic Antitumor Responses
  by: Hampartsoum B. Barsoumian, et al.
  Published: (2022-01-01)
• 200 NBTXR3 nanoparticle with immunoradiation improves survival and generates long-term anti-tumor memory in an anti-PD1 resistant murine lung cancer model
  by: James Welsh, et al.
  Published: (2020-11-01)
• Pulsed radiotherapy to mitigate high tumor burden and generate immune memory
  by: Duygu Sezen, et al.
  Published: (2022-10-01)